Addressing Barriers to Clinical Trial Participation for Transgender People With Cancer to Improve Access and Generate Data

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Ash B. Alpert

Honoraria: CME Outfitters

Susanne Miedlich

Employment: University of Rochester

Research Funding: URMC Department of Medicine

Don S. Dizon

Stock and Other Ownership Interests: Midi

Honoraria: UpToDate

Consulting or Advisory Role: i-Mab, AstraZeneca, Pfizer, Midi, Clovis Oncology

Research Funding: Bristol Myers Squibb (Inst), Pfizer (Inst)

Other Relationship: Global Cancer Institute